Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option

Introduction: Nilotinib is a BCR-ABL tyrosine kinase inhibitor approved for chronic myeloid leukemia. We present a case of severe immune-mediated liver injury by nilotinib treatment. Case report: A 59-year-old woman was referred to the liver clinic because of elevated liver enzyme levels. One year p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyun, Sung, Pil Soo, Jung, Eun Sun, Cho, Sungwoo, Bae, Si Hyun, Kim, Dong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367179/
https://www.ncbi.nlm.nih.gov/pubmed/32754445
http://dx.doi.org/10.3389/fonc.2020.01160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367179/
https://www.ncbi.nlm.nih.gov/pubmed/32754445
http://dx.doi.org/10.3389/fonc.2020.01160

Ejemplares similares